aid: ideaya-biosciences
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/ideaya-biosciences.png
name: Ideaya Biosciences
description: >-
  IDEAYA Biosciences is a clinical-stage precision medicine oncology company headquartered
  in South San Francisco, California (NASDAQ IDYA), focused on discovering, developing, and commercializing
  targeted therapeutics for genetically defined cancer patient populations. Its research spans PKC
  inhibition in uveal melanoma, antibody-drug conjugate and DNA-damage-response combinations, synthetic-lethal
  MTAP-pathway programs, and KAT6/7 epigenetic inhibition, led by the investigational candidate darovasertib
  in registrational uveal melanoma trials. The company maintains a corporate and investor-relations web
  presence and does not currently publish a public developer API.
url: https://raw.githubusercontent.com/api-evangelist/ideaya-biosciences/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Life Sciences
- Clinical Trials
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ideaya-biosciences-domain-security.yml
- type: Website
  url: https://ideayabio.com
- type: Blog
  url: https://media.ideayabio.com/overview
  name: Newsroom
- type: Support
  url: https://ideayabio.com/contact
  name: Contact
- type: PrivacyPolicy
  url: https://ideayabio.com/privacy-policy/
- type: TermsOfService
  url: https://ideayabio.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence